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Background: Determining the incidence, progression, and patterns of multimorbidity
are important for the prevention, management, and treatment of concurrence of multiple
conditions. This study aimed to analyzemajor multimorbidity patterns and the association
of the onset of a primary condition or combinations of a primary and a secondary
condition with the progression to subsequent conditions.
Methods: We included 53,867 participants aged 45–64 years from the 45 and Up
Study who were free of 10 predefined chronic conditions at baseline (2006–2009). The
incidence of multimorbidity (coexistence of ≥2, ≥3, and ≥4 conditions) was identified
using the claims database until December 31, 2016. The primary, secondary, tertiary,
and quaternary condition for each participant was defined according to its temporal order
of onset.
Results: During a mean 9-years follow-up, the cumulative incidence of primary,
secondary, tertiary, and quaternary conditions was 49.6, 23.7, 9.0, and 2.9%,
respectively. The time to develop a subsequent condition decreased with the
accumulation of conditions (P < 0.0001). Two concurrent cardiometabolic disorders
(CMDs, 30.4%) and CMDs clustered with musculoskeletal disorders (15.2%), mental
disorders (13.5%), asthma (12.0%), or cancer (8.7%) were the five most common
multimorbidity patterns. CMDs tended to occur prior to mental or musculoskeletal
disorders but after the onset of cancers or asthma. Compared with all participants
who developed cancer as a primary condition, individuals who experienced mental
disorders/neurodegenerative disorders and a comorbidity as cardiovascular disease,
hypertension, dyslipidemia, diabetes, asthma, or osteoarthritis were 3.36–10.87 times
more likely to develop cancer as a tertiary condition. Individuals with neurodegenerative
disorders and a comorbidity as hypertension, dyslipidemia, osteoarthritis, or asthmawere
5.14–14.15 times more likely to develop mental disorders as a tertiary condition.
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Conclusions: A high incidence of multimorbidity in middle-aged adults was observed
and CMDs were most commonly seen in multimorbidity patterns. There may be
accelerated aging after a primary condition occurs. Our findings also reveal a potential
preventative window to obviate the development of secondary or tertiary conditions.
Keywords: patterns of multimorbidity, time to develop subsequent conditions, primary condition, secondary
condition, tertiary condition, quaternary condition
INTRODUCTION
In Australia, 91% of the total mortality was attributed to
chronic conditions in 2016 (1), among which cardiovascular
disease (CVD), cancer, dementia/Alzheimer disease, and diabetes
accounted for a predominant proportion of these mortality
cases (2). Although hypertension, dyslipidemia, asthma, mental
disorders, and musculoskeletal disorders may not be the direct
causes of mortality, they are leading contributors to disease
burden globally (2–4). Physiological degeneration with aging
is associated with numerous chronic conditions (5), and these
conditions have overlapping etiologies and risk factors resulting
into a phenomenon that many individuals have not only one but
several conditions in the aging population. The concurrence of
two or more of chronic conditions (multimorbidity) has posed a
tremendous burden on the health care system (6–11).
An increasing number of studies have investigated the
prevalence and patterns of multimorbidity (12–14), however,
most of them on multimorbidity pattern focused merely on the
analysis of possible combinations of two or three conditions
and are limited by cross-sectional design (13). Data on which
chronic condition is more likely to come first, how clusters
of conditions develop and change over time (12, 15), and
whether the existence of a condition would reduce the time
to progress to a subsequent one are limited. A few studies
have explored the associations between multiple conditions.
However, these studies are limited by failing to identify
which condition came first given that medical history was not
collected at baseline (16, 17). A recent longitudinal study on
diabetes, heart disease, and stroke multimorbidity suggested
that the onset of stroke was more likely to trigger two
subsequentconditions (18). The complex interaction between
multiple chronic conditions including asthma, cancer, and
cardiometabolic disorders (CMDs), musculoskeletal, mental, and
neurodegenerative disorders is unclear.
We examined the incidence of multimorbidity with multiple
chronic conditions (≥2, ≥3, or ≥4) and the time to develop
a subsequent condition. We also identified multimorbidity
patterns by computing all combinations and permutations of
multiple conditions and investigated the associations between the
onsets of multiple chronic conditions.
MATERIALS AND METHODS
Participants
The Sax Institute’s 45 and Up Study is a prospective study of
266,896 participants aged 45 years and over in New South Wales
(NSW), Australia between 2006 and 2009 (19). Participants were
randomly selected from the general population through the
Department of Human Services (formerly Medicare Australia)
enrolment database, with an 18% participation rate [similar to
previous studies of this kind (20, 21)]. The sample corresponds to
11% of the entire NSW population in the target age group (22).
Baseline data collected using an administrative questionnaire
were linked to the Medicare Benefits Schedule (MBS) and
Pharmaceutical Benefits Scheme (PBS) data (July 1, 2004, and
December 31, 2016) by the Sax Institute using a unique
identifier provided by the Department of Human Services.
This analysis excluded participants with any of 10 chronic
conditions at baseline: cancer (excluded non-melanoma skin
cancer), CVD (heart disease, stroke), hypertension, dyslipidemia,
diabetes, asthma, mental disorders (depression and anxiety),
neurodegenerative disorders (dementia and Parkinson’s disease),
hip replacement, and osteoarthritis based on self-reported
history of previous diagnosis, MBS, or PBS claims; those
with Department of Veterans’ Affairs Health cards because
information on these people is not included in claimed data; or
those who needed help with daily tasks because of long-term
illness/disability at baseline (Additional File 1: Figure S1).
The 45 and Up study has ethical approval from the UNSW
Human Research Ethics Committee. Approval to use data from
the 45 and Up Study for the current study was received from the
Royal Victorian Eye and Ear Hospital Human Research Ethics
Committee. Participants provided consent to follow-up and link
their data to routine health datasets.
Outcome Variables
The main outcomes of interest were the incidence of the
10 chronic conditions, which were identified by the date of
record in PBS or MBS. Several definitions of multimorbidity
from a combination of multiple conditions (≥2, ≥3, or ≥4)
out of the 10 chronic conditions were tested. We regarded
the chronic conditions as primary, secondary, tertiary, and
quaternary according to its temporal onset order. We further
categorized the 10 conditions into six groups including
CMDs (CVD, diabetes, hypertension, and dyslipidemia), cancer,
asthma, mental disorders, neurodegenerative disorders, and
musculoskeletal disorders (hip replacement and osteoarthritis)
for the multimorbidity pattern analysis. PBS and MBS codes for
each chronic condition were listed inAdditional File 1: Table S1.
Co-variates
Information including age, gender, ethnicity, income, education,
health insurance, lifestyle, diets, and family history of conditions
was assessed using an administrative questionnaire, which
Frontiers in Public Health | www.frontiersin.org 2 August 2020 | Volume 8 | Article 404
Shang et al. Incidence, Progression, Patterns of Multimorbidity
is available at http://www.saxinstitute.org.au/our-work/45-up-
study/questionnaires/. Body mass index (BMI) was calculated
based on self-reported height and weight. We created an
additional “missing” category for each covariate for those with
missing values.
Statistical Analysis
Descriptive data were summarized as frequency and percentage
according to age and gender. Cox regression models were used
to compare the incidence of multimorbidity between genders
and between age groups after adjustment for the country of
birth, income, education, BMI and health insurance, and mutual
adjustment for gender and age.
We used the Wilcoxon rank-sum test to examine whether
the median time to develop a subsequent condition differed
between genders or age groups. The trend of the time to develop a
subsequent condition for the accumulation of chronic conditions
was examined using the Mann-Kendall test.
We analyzed all combinations and permutations of 2–4
conditions to identify the major multimorbidity patterns. Chi-
square test was used to examine the difference in the contribution
of each condition between primary and secondary onsets while
the Cochran-Armitage test was used to assess the trend in
the contribution of each condition with the accumulation
of conditions.
The associations of the onset of a primary condition with
progression to a secondary condition and a combination of
a primary and a secondary condition with progression to a
tertiary condition were assessed using Poisson regression models
with a robust variance for relative risks (RRs) (95% confidence
interval [CI]) calculation. The reference was the incidence of
the corresponding primary condition within 5 years in all
participants who were free of any of 10 chronic conditions
at baseline. For example, to examine whether hypertension as
the primary condition would increase the risk of cancer as the
secondary condition, the comparison was conducted between
the incidence of cancer as the second condition in participants
with hypertension as the primary condition, and cancer as the
primary condition in the total population (Additional File 1:
Figure S2). To enable comparison, the onset of the primary,
secondary, and tertiary condition was restricted to the cases that
occurred within the first 5 years for this specific analysis, where
participants with follow-up time <5 years for the secondary
or tertiary condition were excluded. The time to develop a
subsequent condition was computed by subtracting the onset
date of the existing condition from the onset date of the
subsequent condition. The multivariable-analysis was adjusted
for age, gender, income, education, health insurance, relative
socioeconomic disadvantage, residential rurality, family history
of conditions, BMI, diets, and lifestyles. Benjamin-Hochberg
procedure was used to control the false discovery rate level at 5%
for multiple comparisons (23).
We did sensitivity analysis for multimorbidity patterns
defined by self-reported medical history and claims data at
baseline in 156,835 individuals aged 45–64 years.
Analyses were performed using SAS version 9.4 (SAS Institute
Inc.) and all P-values were two-sided.
RESULTS
Participant Characteristics
As shown in Figure S1, 53,867 participants aged 45–64 years
(56.5% female) at baseline with a mean follow-up of 8.9 (SD =
0.9, range: 7.0–11.5) years were included in the analysis. Men
were more likely to be older, of higher income and education
compared with women (all P < 0.001, Table 1).
Multimorbidity Incidence by Age and
Gender
Men (49.7%) and women (49.5%) had a similar incidence of a
primary condition. Men had a higher incidence of secondary
[multivariable-adjusted HR (95%): 1.07 (1.03–1.11)], tertiary
[1.20 (1.14–1.27)] and quaternary condition [1.26 (1.14–1.39), all
P < 0.001] than women after adjustment for confounders. The
difference in the incidence of multimorbidity between genders
increased with the accumulation of conditions.
Men aged 55–64 years had a higher incidence of primary
[multivariable-adjusted HR (95%): 1.56 (1.50–1.61)], secondary
[1.75 (1.66–1.85)], tertiary [2.02 (1.86–2.19)], and quaternary
conditions [2.18 (1.89–2.53)] than those aged 45–54 years (all P
< 0.001). Similar results were found in women. The difference in
the incidence of multimorbidity between individuals aged 55–64
and 45–55 years increased with the accumulation of conditions
in both men and women (Figure 1).
Time Gap to Develop a Subsequent
Condition by Age and Gender
The time to develop a subsequent condition decreased with the
accumulation of conditions in both men and women (both P
< 0.001). The median (interquartile range) time to develop a
new condition as the primary, secondary, tertiary and quaternary
condition was 4.7 (2.3–6.7), 1.4 (0.3–3.3), 1.0 (0.3–2.4), and 0.8
(0.2–1.9) years, respectively, in men and 4.6 (2.1–6.6), 1.7 (0.6–
3.5), 1.1 (0.4–2.3), and 0.9 (0.2–1.9) years, respectively, in women.
Younger individuals had 1.0 years longer to develop a primary
condition (P < 0.001) but a similar time to develop a secondary,
tertiary, and quaternary condition compared with their older
counterparts (Figure 2).
Patterns of Multimorbidity
During follow-up, the overall incidence of primary, secondary,
tertiary, and quaternary conditions was 49.6, 23.7, 9.0, and
2.9%, respectively. Among participants with ≥2 chronic
conditions, CMDs were seen in all the five most frequent
multimorbidity patterns and were more likely to occur before
mental/musculoskeletal disorders and after cancer/asthma. The
combination of two CMDs (37.8%), CMDs-musculoskeletal
disorders (17.5%), CMDs-asthma (10.3%), CMDs-mental
disorders (10.0%), and CMDs-cancer (8.5%) were the five
leading multimorbidity patterns in men. The five leading
multimorbidity patterns in women were the same whereas a
lower proportion (24.3%) of two CMDs and a higher proportion
of CMDs-mental disorders (16.5%) were observed in women
(Figure 3).
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TABLE 1 | Baseline characteristics by gender.
Variables Men Women
Age
45–54 years 13,163 (56.2) 18,530 (60.9)a
55–64 years 10,253 (43.8) 11,921 (39.1)
Country of birth
Australia 17,193 (73.4) 22,602 (74.2)
Others 6,105 (26.1) 7,732 (25.4)
Missing 118 (0.5) 117 (0.4)
Income
<20,000 AUD 1,120 (4.8) 2,129 (7.0)
20,000–39,999 AUD 2,534 (10.8) 4,360 (14.3)
40,000–69,999 AUD 5,659 (24.2) 6,730 (22.1)
≥70,000 AUD 11,202 (47.8) 10,685 (35.1)
Missing 2,901 (12.4) 6,547 (21.5)
Education
<10 years 1,238 (5.3) 1,713 (5.6)
High school/TAFEb 14,008 (59.8) 18,868 (62.0)
University or higher 7,932 (33.9) 9,616 (31.6)
Missing 238 (1.0) 254 (0.8)
Insurancec
Private with extras 12,893 (55.1) 17,207 (56.5)
Private no extras 3,536 (15.1) 4,195 (13.8)
Health care concession 1,298 (5.5) 2,330 (7.7)
None of the above 5,345 (22.8) 6,327 (20.8)
Missing 344 (1.5) 392 (1.3)
Residential ruralityd
Major cities 12,464 (53.2) 15,819 (51.9)
Inner regional 7819 (33.4) 10,669 (35.0)
Outer regional 2,347 (10.0) 3,022 (9.9)
Remote 233 (1.0) 320 (1.1)
Missing 553 (2.4) 621 (2.0)
Relative socioeconomic disadvantagee
1st quintile 3563 (15.2) 4664 (15.3)
2nd quintile 4300 (18.4) 5758 (18.9)
3rd quintile 4287 (18.3) 5855 (19.2)
4th quintile 4366 (18.6) 5444 (17.9)
5th quintile 6186 (26.4) 7892 (25.9)
Missing 714 (3.0) 838 (2.8)
Body mass indexf
15–18.4 kg/m2 127 (0.5) 503 (1.7)
18.5–24.9 kg/m2 7,930 (33.9) 15,401 (50.6)
25–29.9 kg/m2 10,688 (45.6) 8,421 (27.7)
≥30 kg/m2 3,567 (15.2) 4,232 (13.9)
Missing 1,104 (4.7) 1,894 (6.2)
Smoking
Never 13,445 (57.4) 19,769 (64.9)
Former 7,689 (32.8) 8,458 (27.8)
Current 2,276 (9.7) 2,217 (7.3)
Missing 6 (0.0) 7 (0.0)
Alcohol consumptiong
None 4,456 (19.0) 9,542 (31.3)
1–4 sessions/week 4,767 (20.4) 7,852 (25.8)
5–7 sessions/week 3,438 (14.7) 5,041 (16.6)
7–14 sessions/week 5,028 (21.5) 5,630 (18.5)
(Continued)
TABLE 1 | Continued
Variables Men Women
≥15 sessions/week 5,541 (23.7) 2,081 (6.8)
Missing 186 (0.8) 305 (1.0)
Physical activity
0–4 sessions/week 3,946 (16.9) 4,479 (14.7)
5–9 sessions/week 6,262 (26.7) 9,191 (30.2)
10–14 sessions/week 5,127 (21.9) 7,649 (25.1)
≥15 sessions/week 7,512 (32.1) 8,478 (27.8)
Missing 569 (2.4) 654 (2.1)
Red meat intake
0 or 1 serving per week 2,511 (10.7) 4,423 (14.5)
2 servings per week 3,964 (16.9) 5,276 (17.3)
3 or 4 servings per week 7,661 (32.7) 10,518 (34.5)
5 or more servings per week 4,638 (19.8) 4,002 (13.1)
Missing 4,642 (19.8) 6,232 (20.5)
Vegetable intake
0 or 1 serving per day 3,781 (16.1) 1,749 (5.7)
2 servings per day 7,785 (33.2) 6,721 (22.1)
3 servings per day 3,791 (16.2) 5,182 (17.0)
4 servings per day 2,852 (12.2) 5,543 (18.2)
5 or more servings per day 4,644 (19.8) 10,400 (34.2)
Missing 563 (2.4) 856 (2.8)
Fruits intake
None 2,273 (9.7) 1,527 (5.0)
1 serving per day 8,710 (37.2) 8,956 (29.4)
2 servings per day 6,409 (27.4) 10,770 (35.4)
3 or more servings per day 4,733 (20.2) 7,825 (25.7)
Missing 1,291 (5.5) 1,373 (4.5)
aData are expressed as No. (%) unless otherwise indicated.
bTAFE refers to Technical and Further Education.
cExtras cover is a type of health insurance policy that provides a benefit toward the cost
of general treatment outside of a hospital while those with health care concession cards
can get access to cheaper medicines and concessions on services.
dResidential rurality was categorized as four groups including major cities, inner regional
area, outer regional area, and remoteness using the Accessibility Remoteness Index
of Australia.
eRelative socioeconomic disadvantage was divided into quintiles, with the lowest quintile
representing the greatest socio-economic disadvantage.
fBody mass index was calculated as weight in kilograms divided by the square of height
in meters.
gSessions of alcohol consumption per week represents times of alcohol consumption
per week.
As shown in Additional File 1: Tables S2–S4, CMDs
had a high contribution in primary, secondary, tertiary, and
quaternary conditions. There was a decreasing trend in the
contribution of asthma and an increasing trend in that of
osteoarthritis and mental disorders with the accumulation
of conditions.
Five most frequent patterns contributed to 60.4% of 112
combinations of three conditions (Additional File 1: Table S5)
and 47.5% of 134 combinations of four conditions with CMDs
being seen in all these patterns (Additional File 1: Table S6).
Combinations and permutations of two to four incident
conditions with each condition as an individual group are listed
in (Additional File 1: Tables S7–S12).
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FIGURE 1 | Incidence of a primary, secondary, tertiary, and quaternary chronic condition in middle-aged men and women. (A–C) show the incidence of primary,
secondary, tertiary, and quaternary chronic conditions in total population, men and women, respectively. Proportional Cox regression models were used to compare
the incidence of multimorbidity between genders and between age groups after adjustment for the country of birth, income, education, BMI, and health insurance.
Gender and age were mutually adjusted for.
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FIGURE 2 | Time to develop a subsequent condition in middle-aged men and women. (A–C) show the time to develop a subsequent chronic condition in total
population, men and women, respectively. The horizontal lines that form the top and bottom of the box refer to the 75th percentile (Q3) and 25th percentile (Q1), while
the horizontal line in the middle of the box is the median. P-value for the trend of the time to develop a subsequent condition for the accumulation of conditions was
computed using the Mann-Kendall test.
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FIGURE 3 | Major multimorbidity patterns in middle-aged men and women. The multimorbidity patterns were examined using the combination and permutation of the
first two chronic conditions in 12,753 participants (54.7% women). (A–C) show major multimorbidity patterns of two conditions in total population, men and women,
(Continued)
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FIGURE 3 | respectively. Red bar represents the percentage of a multimorbidity pattern with a condition progressing to another condition while blue bar represents
the percentage of a multimorbidity pattern in the other progression direction. There are 45 combinations and 100 permutations of two chronic conditions available for
the total participants. This figure presents 11 major patterns with each one accounting for more than 2% of the total population. We combined CMDs (cardiovascular
disease, diabetes, dyslipidemia, and hypertension) as one group so as to show the results in this figure in a concise way. All the permutations and combinations of 10
individual conditions for two, three, and four conditions are available in Additional File 1: Tables S7–S12 in the supplement.
Associations of Existing Conditions With
Subsequent Conditions Onset
Individuals with two conditions had a higher risk of incident
cancer compared to those without any condition at baseline.
In the multivariable-analysis, participants with mental disorders
and comorbidity as CVD, hypertension, dyslipidemia, diabetes,
asthma, hip replacement or osteoarthritis were 5.00 [95% CI:
(3.29–7.59)], 6.58 (5.16–8.40), 7.23 (5.75–9.10), 3.37 (1.84–
6.19), 8.50 (6.39–11.31), 5.31 (1.66–16.96), and 7.70 (5.95–
9.96) times more likely to progress to cancer as a tertiary
condition, respectively, compared with the total population who
developed cancer as a primary condition. While individuals
with neurodegenerative disorders and comorbidity as CVD,
hypertension, dyslipidemia, asthma, osteoarthritis or mental
disorders were 10.87 (1.79–66.21), 3.97 (1.65–9.56), 3.88 (1.84–
8.20), 9.47 (3.89–23.09), 6.15 (1.95–19.40) and 4.31 (2.03–9.16)
times more likely to progress to cancer as a tertiary condition,
respectively, compared with the total population who developed
cancer as a primary condition.
Individuals with two conditions as cancer-asthma, cancer-
osteoarthritis, cancer-mental disorders, and asthma-hip
replacement were 2.41–3.98 times to progress to CVD as a
tertiary condition, compared with the total population who
developed CVD as a primary condition.
Individuals with neurodegenerative disorders and
comorbidity as hypertension [multivariable-adjusted RR
(95%): 5.14 (2.07–12.79)], dyslipidemia [6.11 (2.88–12.99)],
asthma [14.15 (5.76–34.77)], or osteoarthritis [10.56 (3.33–
33.48)] had a higher risk of progression to mental disorders
as a tertiary condition, compared with total participants who
developed mental disorders as a primary condition (Figure 4).
Sensitivity Analysis
The prevalence of one, two, three, and four conditions was 65.4,
18.3, 9.7, and 4.4%, respectively. The leading multimorbidity
patterns defined by the combination of two conditions were two-
CMDs (28.1%), CMDs-mental disorders (18.2%), CMDs-asthma
(10.0%), CMDs-cancer (8.8%), and asthma-mental disorders
(8.2%). Three-CMDs (20.3%) were the most frequent pattern
defined by the combination of three prevalent conditions and two
CMDs plus one other chronic condition contributed to 33.5% of
all combinations.
These patterns were consistent with those defined by the
incidence of conditions in our longitudinal analysis (Additional
File 1: Tables S13–S15).
DISCUSSION
Men had a higher risk of developing the secondary,
tertiary, and quaternary conditions than women. The
time to develop a subsequent condition decreased with
the accumulation of conditions in both men and women.
The most common multimorbidity patterns were two
CMDs; CMDs-musculoskeletal disorders, CMDs-mental
disorders, CMDs-asthma, CMDs-cancer, musculoskeletal-
mental disorders, and asthma-musculoskeletal disorders.
Participants with a primary condition including CMDs, asthma
or osteoarthritis were more likely to progress to subsequent
cancer and mental disorders, while individuals with degenerative
or mental disorders and a comorbidity as any of CMDs,
musculoskeletal disorders or asthma had a higher risk of
progression to cancer as the tertiary condition.
We found men had a higher risk of developing the secondary,
tertiary, and quaternary conditions than women, and the
magnitude increased with the accumulation of conditions. In
contrast, previous cross-sectional studies from Europe, the US,
and Australia demonstrated that women had a higher prevalence
of multimorbidity than men (13). One explanation for the
inconsistency is the different chronic conditions that used
to define multimorbidity in our study considering the sexual
difference in the prevalence/incidence of individual conditions
(24, 25). Furthermore, we used the incidence of multimorbidity
among participants who were free of 10 chronic conditions
at baseline. However, Violan et al. analyzed the prevalence
of multimorbidity based on cross-sectional studies, which are
subject to bias. Men were more incidental in CVD, hypertension,
dyslipidemia, diabetes than women (24, 25), and these conditions
were more likely to be clustered with other conditions (26),
resulting in a higher incidence of two or more conditions in men.
The shorter time to develop a subsequent condition observed in
men than women in our study also validated this association.
Our study is consistent with previous studies showing a
strong association between age and incidence of multimorbidity
(13). We further found younger individuals had 1 year longer
to develop a primary condition than their older counterparts,
however, they did not differ in the time to develop a secondary,
tertiary, and quaternary condition suggesting there may be
accelerated aging after the occurrence of a first condition. This
highlights the importance of the prevention of primary condition
at an early stage of life course and also provides evidence for why
there is a high global prevalence of multimorbidity in adults aged
<65 years (12).
Five most frequent multimorbidity patterns of two conditions
were two CMDs, and a CMD clustered with musculoskeletal
disorders, mental disorders, asthma, or cancer in our study.
Several common patterns including cardiorespiratory, metabolic,
and mentalarticular disorders were identified across several
countries in a cross-sectional study of 41,909 adults (14). A
systematic review of cross-sectional studies reported that the
three most common patterns were CMDs, mental health-related
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FIGURE 4 | The association of the onset of a primary condition or combinations of the onset of a primary and a secondary condition with progression to a subsequent
condition. CI, confidence interval; CVD, cardiovascular disease; RR, relative risk. The graph shows the relative risk (95% CI) for progression to a secondary condition in
the top row associated with a primary condition in the left column as well as the relative risk for progression to a tertiary condition in the top row associated with
combinations of two existing conditions in the left column. The number of participants listed represents those with a primary condition or a combination of a primary
and a secondary condition in the left column. Participants who were free of any of 10 chronic conditions at baseline were the reference for all comparisons. The
associations of the onsets of each of 10 primary conditions with the progression to each of 10 secondary conditions and each of 44 combinations of a primary and a
secondary condition with the progression to each of 10 tertiary conditions were examined. Given the multiple comparisons, only significant associations with the false
discovery rate <0.05 were presented in this figure. Poisson regression was used to estimate the relative risk that adjusted for age, gender, income, education, body
mass index, and health insurance. Green and red colors indicate inverse and positive association, respectively, and color intensity is proportional to the size of relative
risks. a Further analysis showed the multivariate-adjusted RR (95% CI) for progression to CVD as the secondary condition was 6.27 (5.50–7.15) in individuals with
hypertension as the primary condition after adjustment for age, gender, income, education, body mass index, and health insurance when the interplay analysis was
restricted to these two conditions. b Two combinations with 1–4 participants are not present in this figure due to participant confidentiality reasons. Neither of these
combinations was associated with the onset of any of the tertiary conditions. The results for quaternary condition are not shown in Figure 4, as 93 out of 112
combinations of the first three conditions has 10 or fewer participants resulting in low statistical power to test significant associations for these combinations.
problems, and musculoskeletal disorders (26). We observed
CMDs were most commonly clustered with other conditions
with 10 most frequent patterns of first three conditions having
at least one being a CMD. Another systematic review of cross-
sectional studies highlighted depression was most commonly
clustered with other conditions, followed by hypertension,
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diabetes, and heart disease (27). Although these studies identified
various multimorbidity patterns, the order of onset is unclear.
Our study demonstrated that CMDs tended to follow the onset
of asthma and cancer but precede the onset of musculoskeletal
and mental disorders. This provides further evidence regarding
the progression of multimorbidity, potentially translating to
intervention action for the prevention and management of
concurrence of multiple conditions (14).
The relationship of mental disorders with osteoarthritis (28),
cardiometabolic disorders (29), cancer (30), dementia (31), and
Parkinson’s disease (32, 33) has been reported in previous
studies. Chronic pain, disability, adverse effects on lifestyle as
well as the he perceived loss of health, functional capability and
independence in patients with these physical chronic diseases
may partly explain the increased risk of mental disorders
(34–39). The association of asthma with osteoarthritis and
mental disorders is less known. Our study is consistent with a
previous study showing that adult-onset asthma is commonly
seen and is associated with numerous chronic diseases such
as obesity, diabetes, and mental disorders (40). The common
factor behind these unexpected links between diseases may be
the systemic or quiet inflammation (41). The co-existence of
asthma with chronic obstructive pulmonary disease may also
partly explain the association between asthma and diabetes
and mental disorders. Asthma has also been shown to be a
risk factor of developing rheumatoid arthritis (42), but more
studies are needed to explore its association with osteoarthritis.
The relationships of osteoarthritis with cardiometabolic and
mental disorders have been observed in many studies (28, 43),
but the association between osteoarthritis and cancer is not
clear. Emerging evidence suggests rheumatoid arthritis may
increase the risk of lung and lymphoma malignancies (44, 45),
which might provide justification for the connection between
osteoarthritis and cancer.
Despite established literature demonstrating the one to
one associations between CMDs, asthma, osteoarthritis,
neurodegenerative disorders, cancer, and mental disorders
(44, 46–52), it has been unclear whether the clustering of two
conditions increases the risk of developing a tertiary condition.
In relation to cancer as an outcome, our study agrees with
previous studies (44, 46, 47, 49, 50, 52), showing that the onset
of a primary condition including CMDs, asthma, osteoarthritis,
and neurodegenerative disorders was each positively associated
with the incidence of cancer as the secondary condition. Whilst
mental disorders as a comorbidity of any of these conditions have
the potential to substantially increase the hazardous effect on the
progression to cancer, no significant association between mental
disorders as a primary condition and cancer as a secondary
condition was seen. Looking at mental disorders as an outcome,
all conditions except diabetes and hip replacement were each
associated with a higher risk of progression to mental disorders
as a secondary condition. Furthermore, when osteoarthritis as
a comorbidity occurred, there was an even stronger association
with the incidence of mental disorders. These findings suggest
a potential synergistic effect among primary and secondary
conditions on the development of some tertiary conditions
including cancer and mental disorders and highlight the
importance of the prevention, management, and treatment of
the primary conditions to prevent or delay the development
of subsequent conditions. For CVD, we observed a potential
treatment effect that there is an inverse association between
the onset of hypertension as a primary condition and CVD
as a secondary condition. However, further analysis showed
that participants with hypertension as the primary condition
were 6.27 times more likely to develop CVD as a secondary
condition when the other eight conditions were not taken into
consideration and they were more likely to firstly progress
to dyslipidemia, osteoarthritis, mental disorders or asthma
than to CVD. This indicates that well-treated hypertension
patients might be less likely to progress to CVD in 5 years
but the occurrence of a comorbidity would heighten the risk.
Future work needs to explore how much of the association
between two conditions is mediated by the intermediate onset of
another one and whether some associations are caused by other
intermediate conditions.
To our knowledge, this is the first study to comprehensively
examine the incidence of multimorbidity, time to develop a
subsequent condition, and which condition was more likely
to come first in a community-dwelling population with large
sample size and long-term follow-up. This study is also unique in
having examined associations of the combinations of a primary
and a secondary condition with the risk of progression to
tertiary conditions.
Some limitations need to be considered in our study. First, all
chronic conditions are weighted equally, with a simple number
to define multimorbidity in the analysis of incidence and time
to develop a new condition in our study. Furthermore, only 10
chronic conditions with available data on medical history were
included in our analysis, although these conditions contributed
around three quarters (74.9%) of total death in Australia in
2016 (3). The generalizability of our findings regarding the
multimorbidity patterns may be limited given the selection of
conditions as well as the exclusion of participants with any
of the predefined conditions at baseline. Finally, some of the
primary, secondary, tertiary, and quaternary conditions were
dependent, which might result in some of the associations
between conditions not being independent of other conditions
and small standard errors.
In conclusion, we found a high incidence of multimorbidity
and CMDs were most often clustered with other conditions
in middle-aged men and women, highlighting the importance
of early intervention. There may be accelerated aging after
a primary condition occurs. Our findings also reveal a
potential preventative window to obviate the development of
secondary or tertiary conditions. These findings may help target
priority interventions for the prevention and management of
multimorbidity at an early stage and guide the screening of
subsequent conditions in primary care.
DATA AVAILABILITY STATEMENT
The datasets presented in this article are not readily available
because the data that support the findings of this study are
Frontiers in Public Health | www.frontiersin.org 10 August 2020 | Volume 8 | Article 404
Shang et al. Incidence, Progression, Patterns of Multimorbidity
available from The Sax Institute but restrictions apply to the
availability of these data, which were used under license for the
current study, and so are not publicly available. Data are however
available from the authors upon reasonable request and with
permission of The Sax Institute. Requests to access the datasets
should be directed to https://www.saxinstitute.org.au/our-work/
45-up-study.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by The 45 and Up study has ethical approval from
the UNSW Human Research Ethics Committee. Approval to
use data from the 45 and Up Study for the current study was
received from the Royal Victorian Eye and Ear Hospital Human
Research Ethics Committee. Participants provided consent to
follow-up and link their data to routine health datasets. The
patients/participants provided their written informed consent to
participate in this study.
AUTHOR CONTRIBUTIONS
XS, LZ, and MH conceived and designed the research. XS and LZ
conducted data analysis and interpretation. XS wrote the initial
draft of the manuscript. XS, LZ, CS, WP, EH, andMH revised the
manuscript. All authors read and approved the final manuscript.
FUNDING
MH receives support from the University of Melbourne at
Research Accelerator Program and the Center for Eye Research
Australia Foundation. The Center for Eye Research Australia
receives Operational Infrastructure Support from the Victorian
State Government. The specific project was funded by the
Australia China Research Accelerator Program at Center for Eye
Research Australia. Professor Mingguang He is also supported by
the Fundamental Research Funds of the State Key Laboratory in
Ophthalmology, National Natural Science Foundation of China
(81420108008). The sponsor or funding organization had no role
in the design or conduct of this research. LZ was supported
by the National Natural Science Foundation of China (Grant
number: 8191101420); Outstanding Young Scholars Funding
(Grant number: 3111500001); Xi’an Jiaotong University Basic
Research and Profession Grant (Grant number: xtr022019003)
and Xi’an Jiaotong University Young Talent Support Grant
(Grant number: YX6J004). CS was supported by the National
Health and Medical Research Council.
ACKNOWLEDGMENTS
This research was completed using data collected through
the 45 and Up Study (www.saxinstitute.org.au). The 45 and
Up Study is managed by the Sax Institute in collaboration
with major partner Cancer Council NSW; and partners: the
National Heart Foundation of Australia (NSW Division); NSW
Ministry of Health; NSW Government Family & Community
Services–Aging, Carers and the Disability Council NSW; and
the Australian Red Cross Blood Service. We thank the other
investigators, staff, and participants of the 45 and Up Study
cohort for their important contributions.
SUPPLEMENTARY MATERIAL




1. World Health Statistics. World Health Statistics 2018: Monitoring Health
for the SDGs, Sustainable Development Goals. Geneva: World Health
Organization (2018).
2. Australian Institute of Health and Welfare. AIHW National Mortality
Database. Canberra: Australian Institute of Health and Welfare (2017).
3. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE,
et al. Global burden of disease attributable to mental and substance use
disorders: findings from the global burden of disease study 2010. Lancet.
(2013) 382:1575–86. doi: 10.1016/S0140-6736(13)61611-6
4. GBD 2015 Risk Factors Collaborators. Global, regional, and national
comparative risk assessment of 79 behavioural, environmental and
occupational, and metabolic risks or clusters of risks, 1990-2015: a
systematic analysis for the global burden of disease study 2015. Lancet.
(2016) 388:1659–724. doi: 10.1016/S0140-6736(16)31679-8
5. Shang X, Wang W, Keel S, Wu J, He M, Zhang L. Leading determinants
for disease-free status in community-dwelling middle-aged men and women:
a 9-year follow-up cohort study. Front Public Health. (2019) 7:320.
doi: 10.3389/fpubh.2019.00320
6. Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M,
et al. Review: health care utilization and costs of elderly persons with
multiple chronic conditions. Med Care Res Rev. (2011) 68:387–420.
doi: 10.1177/1077558711399580
7. Parekh AK, Barton MB. The challenge of multiple comorbidity for the US
health care system. JAMA. (2010) 303:1303–4. doi: 10.1001/jama.2010.381
8. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of
comorbidity with disability in older women: the women’s health and aging
study. J Clin Epidemiol. (1999) 52:27–37. doi: 10.1016/S0895-4356(98)00124-3
9. Ryan A, Wallace E, O’Hara P, Smith SM. Multimorbidity and functional
decline in community-dwelling adults: a systematic review. Health Qual Life
Outcomes. (2015) 13:168. doi: 10.1186/s12955-015-0355-9
10. Nunes BP, Flores TR, Mielke GI, Thume E, Facchini LA. Multimorbidity and
mortality in older adults: a systematic review andmeta-analysis.Arch Gerontol
Geriatr. (2016) 67:130–8. doi: 10.1016/j.archger.2016.07.008
11. Ording AG, Sorensen HT. Concepts of comorbidities, multiple morbidities,
complications, and their clinical epidemiologic analogs. Clin Epidemiol.
(2013) 5:199–203. doi: 10.2147/CLEP.S45305
12. The Academy of Medical Sciences. Multimorbidity: A Priority for Global
Health Research. London: The Academy of Medical Sciences (2018).
13. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag
M, et al. Prevalence, determinants and patterns of multimorbidity in
primary care: a systematic review of observational studies. PLoS ONE. (2014)
9:e102149. doi: 10.1371/journal.pone.0102149
14. Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M,
et al. Global multimorbidity patterns: a cross-sectional, population-based,
multi-country study. J Gerontol A Biol Sci Med Sci. (2016) 71:205–14.
doi: 10.1093/gerona/glv128
15. Schafer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, et al.
The influence of age, gender and socio-economic status on multimorbidity
patterns in primary care. first results from the multicare cohort study. BMC
Health Serv Res. (2012) 12:89. doi: 10.1186/1472-6963-12-89
Frontiers in Public Health | www.frontiersin.org 11 August 2020 | Volume 8 | Article 404
Shang et al. Incidence, Progression, Patterns of Multimorbidity
16. Hidalgo CA, Blumm N, Barabasi AL, Christakis NA. A dynamic network
approach for the study of human phenotypes. PLoS Comput Biol. (2009)
5:e1000353. doi: 10.1371/journal.pcbi.1000353
17. Jensen AB, Moseley PL, Oprea TI, Ellesoe SG, Eriksson R, Schmock
H, et al. Temporal disease trajectories condensed from population-wide
registry data covering 6.2 million patients. Nat Commun. (2014) 5:4022.
doi: 10.1038/ncomms5022
18. Xu X, Mishra GD, Dobson AJ, Jones M. Progression of diabetes, heart disease,
and stroke multimorbidity in middle-aged women: a 20-year cohort study.
PLoS Med. (2018) 15:e1002516. doi: 10.1371/journal.pmed.1002516
19. Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, et al.
Cohort profile: the 45 and up study. Int J Epidemiol. (2008) 37:941–7.
doi: 10.1093/ije/dym184
20. Nohr EA, Frydenberg M, Henriksen TB, Olsen J. Does low participation
in cohort studies induce bias? Epidemiology. (2006) 17:413–8.
doi: 10.1097/01.ede.0000220549.14177.60
21. Farrell L, Hollingsworth B, Propper C, Shields MA. The socioeconomic
gradient in physical inactivity: evidence from one million adults in England.
Soc Sci Med. (2014) 123:55–63. doi: 10.1016/j.socscimed.2014.10.039
22. Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD.
Investigation of relative risk estimates from studies of the same population
with contrasting response rates and designs. BMC Med Res Methodol. (2010)
10:26. doi: 10.1186/1471-2288-10-26
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J R Stat Soc Ser. (1995) 57:289–300.
doi: 10.1111/j.2517-6161.1995.tb02031.x
24. Regitz-Zagrosek V. Sex and gender differences in health. EMBO Rep. (2012)
13:596–603. doi: 10.1038/embor.2012.87
25. Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and
depression clinical perspectives. Front Neuroendocrinol. (2014) 35:320–30.
doi: 10.1016/j.yfrne.2014.05.004
26. Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou
B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin
Epidemiol. (2014) 67:254–66. doi: 10.1016/j.jclinepi.2013.09.021
27. Xu X, Mishra GD, Jones M. Evidence on multimorbidity from definition
to intervention: An overview of systematic reviews. Ageing Res Rev. (2017)
37:53–68. doi: 10.1016/j.arr.2017.05.003
28. Stubbs B, Aluko Y, Myint PK, Smith TO. Prevalence of depressive symptoms
and anxiety in osteoarthritis: a systematic review and meta-analysis. Age
Ageing. (2016) 45:228–35. doi: 10.1093/ageing/afw001
29. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P,
et al. Prevalence, incidence and mortality from cardiovascular disease in
patients with pooled and specific severe mental illness: a large-scale meta-
analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry.
(2017) 16:163–80. doi: 10.1002/wps.20420
30. Shang X, Peng W, Hill E, Szoeke C, He M, Zhang L. Incidence
of medication-treated depression and anxiety associated with long-
term cancer, cardiovascular disease, diabetes and osteoarthritis in
community-dwelling women and men. EClinicalMedicine. (2019) 15:23–32.
doi: 10.1016/j.eclinm.2019.08.010
31. Mirza SS, Wolters FJ, Swanson SA, Koudstaal PJ, Hofman A, Tiemeier
H, et al. 10-year trajectories of depressive symptoms and risk of
dementia: a population-based study. Lancet Psychiatry. (2016) 3:628–35.
doi: 10.1016/S2215-0366(16)00097-3
32. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic
review of prevalence studies of depression in Parkinson’s disease.Mov Disord.
(2008) 23:183–9. doi: 10.1002/mds.21803
33. Gustafsson H, Nordstrom A, Nordstrom P. Depression and subsequent risk
of Parkinson disease: a nationwide cohort study.Neurology. (2015) 84:2422–9.
doi: 10.1212/WNL.0000000000001684
34. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and
cardiovascular disease: a clinical review. Eur Heart J. (2014) 35:1365–72.
doi: 10.1093/eurheartj/eht462
35. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress
in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. (2015) 3:450–60.
doi: 10.1016/S2213-8587(15)00135-7
36. Katon WJ, Russo JE, Heckbert SR, Lin EH, Ciechanowski P, Ludman E, et al.
The relationship between changes in depression symptoms and changes in
health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. (2010)
25:466–75. doi: 10.1002/gps.2363
37. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes:
the search for shared mechanisms. Lancet Diabetes Endocrinol. (2015) 3:461–
71. doi: 10.1016/S2213-8587(15)00134-5
38. Wilkie R, Blagojevic-Bucknall M, Jordan KP, Lacey R, McBeth J. Reasons why
multimorbidity increases the risk of participation restriction in older adults
with lower extremity osteoarthritis: a prospective cohort study in primary
care. Arthritis Care Res (Hoboken). (2013) 65:910–9. doi: 10.1002/acr.21918
39. Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, et al.
Effects of intensive diet and exercise on knee joint loads, inflammation,
and clinical outcomes among overweight and obese adults with knee
osteoarthritis: the IDEA randomized clinical trial. JAMA. (2013) 310:1263–73.
doi: 10.1001/jama.2013.277669
40. Ilmarinen P, Tuomisto LE, Niemelä O, Tommola M, Haanpää J,
Kankaanranta H. Cluster analysis on longitudinal data of patients with
adult-onset asthma. J Allergy Clin Immunol Pract. (2017) 5:967–78.e3.
doi: 10.1016/j.jaip.2017.01.027
41. Kankaanranta H, Kauppi P, Tuomisto LE, Ilmarinen P. Emerging
comorbidities in adult asthma: risks, clinical associations, and mechanisms.
Mediators Inflamm. (2016) 2016:3690628. doi: 10.1155/2016/3690628
42. Rolfes MC, Juhn YJ, Wi CI, Sheen YH. Asthma and the risk of rheumatoid
arthritis: an insight into the heterogeneity and phenotypes of asthma. Tuberc
Respir Dis. (2017) 80:113–35. doi: 10.4046/trd.2017.80.2.113
43. Hall AJ, Stubbs B, Mamas MA, Myint PK, Smith TO. Association
between osteoarthritis and cardiovascular disease: systematic
review and meta-analysis. Eur J Prevent Cardiol. (2016) 23:938–46.
doi: 10.1177/2047487315610663
44. Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence
of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.
Arthritis Res Ther. (2015) 17:212. doi: 10.1186/s13075-015-0728-9
45. Morand S, Staats H, Creeden JF, Iqbal A, Kahaleh B, Stanbery L,
et al. Molecular mechanisms underlying rheumatoid arthritis and
cancer development and treatment. Future Oncol. (2020) 16:483–95.
doi: 10.2217/fon-2019-0722
46. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, et al. Diabetes
mellitus and breast cancer outcomes: a systematic review and meta-analysis. J
Clin Oncol. (2011) 29:40–6. doi: 10.1200/JCO.2009.27.3011
47. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome
and risk of cancer: a systematic review and meta-analysis. Diabetes Care.
(2012) 35:2402–11. doi: 10.2337/dc12-0336
48. Qu YL, Liu J, Zhang LX, Wu CM, Chu AJ, Wen BL, et al. Asthma and
the risk of lung cancer: a meta-analysis. Oncotarget. (2017) 8:11614–20.
doi: 10.18632/oncotarget.14595
49. Ng HS, Roder D, Koczwara B, Vitry A. Comorbidity, physical and mental
health among cancer patients and survivors: an Australian population-based
study. Asia Pac J Clin Oncol. (2018) 14:e181–92. doi: 10.1111/ajco.12677
50. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease
progression and mortality in cancer patients: a meta-analysis. Cancer. (2009)
115:5349–61. doi: 10.1002/cncr.24561
51. Peng YH, Wu BR, Su CH, Liao WC, Muo CH, Hsia TC, et al. Adult asthma
increases dementia risk: a nationwide cohort study. J Epidemiol Community
Health. (2015) 69:123–8. doi: 10.1136/jech-2014-204445
52. Gao YH, Zhao HS, Zhang FR, Gao Y, Shen P, Chen RC, et al. The relationship
between depression and asthma: a meta-analysis of prospective studies. PLoS
ONE. (2015) 10:e0132424. doi: 10.1371/journal.pone.0132424
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Shang, Peng, Hill, Szoeke, He and Zhang. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Public Health | www.frontiersin.org 12 August 2020 | Volume 8 | Article 404
